BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32514631)

  • 21. Renal Mass and Localized Renal Cancer: AUA Guideline.
    Campbell S; Uzzo RG; Allaf ME; Bass EB; Cadeddu JA; Chang A; Clark PE; Davis BJ; Derweesh IH; Giambarresi L; Gervais DA; Hu SL; Lane BR; Leibovich BC; Pierorazio PM
    J Urol; 2017 Sep; 198(3):520-529. PubMed ID: 28479239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of small renal masses: An interventional radiologist's perspective.
    Leshen M; Butani D
    Eur J Intern Med; 2019 Jun; 64():15-20. PubMed ID: 31029546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial nephrectomy versus ablative therapies for cT1a renal masses: A Systematic Review and meta-analysis.
    Hu X; Shao YX; Wang Y; Yang ZQ; Yang WX; Li X
    Eur J Surg Oncol; 2019 Sep; 45(9):1527-1535. PubMed ID: 31171480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small renal masses: toward more rational treatment.
    Thomas AA; Campbell SC
    Cleve Clin J Med; 2011 Aug; 78(8):539-47. PubMed ID: 21807926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of surveillance imaging following treatment of small renal masses.
    Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
    J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol.
    Tan YK; Best SL; Olweny E; Park S; Trimmer C; Cadeddu JA
    Urology; 2012 Apr; 79(4):827-30. PubMed ID: 22309782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
    Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
    Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current role of percutaneous needle biopsies of renal tumours.
    Volpe A; Terrone C; Scarpa RM
    Arch Ital Urol Androl; 2009 Jun; 81(2):107-12. PubMed ID: 19760866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous image-guided cryoablation of small renal masses.
    Patel N; King AJ; Breen DJ
    Abdom Radiol (NY); 2016 Apr; 41(4):754-66. PubMed ID: 26915090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review on the Management of Small Renal Masses: Active Surveillance Versus Surgery.
    Marra G; Oderda M; Allasia M; Munegato S; Joniau S; Gontero P
    Anticancer Agents Med Chem; 2018; 18(7):940-950. PubMed ID: 29141564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of surveillance in the management of small renal masses.
    Volpe A
    ScientificWorldJournal; 2007 Apr; 7():860-8. PubMed ID: 17619771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of renal biopsy for small renal masses.
    Ha SB; Kwak C
    Korean J Urol; 2014 Sep; 55(9):568-73. PubMed ID: 25237457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of percutaneous fine needle aspiration biopsy in the management of small renal masses without chance of nephron-sparing surgery.
    Tong W; Lin X; Xu Y; Yan Y
    Int Urol Nephrol; 2020 Dec; 52(12):2223-2228. PubMed ID: 32638215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost comparison of nephron-sparing treatments for cT1a renal masses.
    Castle SM; Gorbatiy V; Avallone MA; Eldefrawy A; Caulton DE; Leveillee RJ
    Urol Oncol; 2013 Oct; 31(7):1327-32. PubMed ID: 22361086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Under-grading of <4 cm renal masses on renal biopsy.
    Harris CR; Whitson JM; Meng MV
    BJU Int; 2012 Sep; 110(6):794-7. PubMed ID: 22404857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications.
    Ward RD; Tanaka H; Campbell SC; Remer EM
    Radiographics; 2018; 38(7):2021-2033. PubMed ID: 30339517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized?
    Couture F; Finelli T; Breau RH; Mallick R; Bhindi B; Tanguay S; Kapoor A; Rendon RA; Pouliot F; Lavallée L; Fairey AS; So A; Richard PO
    Urol Oncol; 2021 Aug; 39(8):499.e15-499.e22. PubMed ID: 34187749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
    Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
    Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization.
    Yoo S; You D; Song C; Hong B; Hong JH; Kim CS; Ahn H; Jeong IG
    Urol Oncol; 2018 Aug; 36(8):362.e9-362.e15. PubMed ID: 29866577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes.
    Borghesi M; Brunocilla E; Volpe A; Dababneh H; Pultrone CV; Vagnoni V; La Manna G; Porreca A; Martorana G; Schiavina R
    Int J Urol; 2015 May; 22(5):432-8. PubMed ID: 25781204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.